Biocytogen Launches RenBiologics A SubBrand Focused on OutLicensing Fully Human Antibodies For Therapeutic Development

Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 today announced the launch of a new subbrand RenBiologics to represent the companys antibody discovery business division.

Related Keywords

San Francisco ,California ,United States ,China ,Beijing ,Shanghai ,Hansoh Pharma ,Junshi Biosciences ,Haimen Jiangsu ,Yuelei Shen ,Chipscreen Newway Biosciences ,Merck Kga ,Development Business ,Biocytogen Pharmaceuticals Beijing Co Ltd ,Merck Kgaa ,Eco Development Business ,Project Integrum ,Rona Therapeutics ,Fully Human ,Platform Licensing Business ,Media Contact ,Biocytogen Pharmaceuticals Renbiologics Human Antibodies Renmice Antibody Tcr Discovery Project Integrum Biopharmaceutical Biotechnology Yuelei Shen Renmab Renlite Rennano Rentcrmimic ,